Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001903238 | SCV002157650 | uncertain significance | not provided | 2021-10-14 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine with cysteine at codon 149 of the COQ7 protein (p.Tyr149Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. This variant is present in population databases (rs760710474, ExAC 0.002%). This missense change has been observed in individual(s) with clinical features of coenzyme Q10 deficiency (PMID: 30369941). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome |
RCV002508971 | SCV002818325 | not provided | Primary coenzyme Q10 deficiency 8 | no assertion provided | phenotyping only | Variant classified as Uncertain significance and reported on 01-04-2022 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
OMIM | RCV002508971 | SCV004242174 | pathogenic | Primary coenzyme Q10 deficiency 8 | 2024-01-31 | no assertion criteria provided | literature only | |
OMIM | RCV003493887 | SCV004242175 | pathogenic | Neuronopathy, distal hereditary motor, autosomal recessive 9 | 2024-01-31 | no assertion criteria provided | literature only |